Cargando…
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients
Concomitant use of adjuvant tamoxifen (TAM) and radiation therapy (RT) is not widely accepted. We aim to assess whether this treatment is associated with an increased risk of developing subcutaneous fibrosis after conservative or radical surgery in breast cancer patients. We analysed 147 women with...
Autores principales: | Azria, D, Gourgou, S, Sozzi, W J, Zouhair, A, Mirimanoff, R O, Kramar, A, Lemanski, C, Dubois, J B, Romieu, G, Pelegrin, A, Ozsahin, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409893/ https://www.ncbi.nlm.nih.gov/pubmed/15328527 http://dx.doi.org/10.1038/sj.bjc.6602146 |
Ejemplares similares
-
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer
por: Azria, David, et al.
Publicado: (2005) -
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial()
por: Azria, David, et al.
Publicado: (2015) -
Letrozole sensitizes breast cancer cells to ionizing radiation
por: Azria, David, et al.
Publicado: (2005) -
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023) -
Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial
por: Lemanski, Claire, et al.
Publicado: (2013)